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Abstract: 
Introduction: Tetanus is an acute neurological but vaccine-preventable disease caused by Clostridium tetani that 
causes significant morbidity and mortality among children in developing countries. Aims and objectives: The 
basic purpose of the study is to analyse the study on risk factors, vaccination status and outcome of tetanus in 
children. Methodology of the study: This cross sectional study was conducted in PIMS, Islamabad during March 
2018 to January 2019. The data was collected from 100 children of both genders. The diagnosis of tetanus was 
clinical, based on medical history and examination, determining the presence of at least three of the following 
clinical findings: severe trismus, refusal to feed, generalised muscle rigidity, opisthotonus or spontaneous tetanic 
spasms. Blood samples were taken within one hour of admission. Laboratory measurements included full blood 
count, electrolytes, creatinine and glucose. Results: The data was collected from 100 patients. There were 
67(63.5%) males and 33 (36.5%) females. Overall, the mean age was 6.56+3.15 years, and the commonest age 
group at presentation was 6-10 years with 38(51.4%) cases. 50(67%) were unvaccinated, none (0%) had received 
booster dose and post-trauma immune prophyl axis. The case fatality was therefore 61.8%, and did not vary 
significantly over the 14 years (P = 0.536). Conclusion: It is concluded that this study has documented high case 
fatality rates in Pediatric tetanus in the study area. 
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INTRODUCTION: 
Tetanus is an acute neurological but vaccine-
preventable disease caused by Clostridium 
tetani that causes significant morbidity and mortality 
among children in developing countries. A recent 
systematic analysis of data from 2000 to 2010 
showed that neonatal tetanus decreased in Africa at 
an annual rate sufficient to attain the Millenium 
Development Goal 4 and it accounted for 20,000–
276,000 neonatal deaths (1% of all child mortality) 
in 2010 [1]. On the other hand, post-neonatal tetanus 
accounted for less than 1% of global child mortality. 
In Nigeria, of the five million babies born annually, 
240,000 (4.8%) die within the first 4 weeks of life 
and tetanus accounts for up to 20% of these deaths 
[2]. 
Neonatal tetanus (NT) continues to be a major cause 
of mortality and neurological sequelae for survivors 
yet it is highly preventable using simple and 
inexpensive public health interventions. In 2013, NT 
was estimated to be responsible for 49,000 deaths, 
mostly in rural areas of developing countries where 
most births occur at home and are often attended by 
unskilled persons using unhygienic practices 
without aseptic postnatal care [3]. NT is estimated to 
contribute about 2% of neonatal deaths in 2012, a 
decrease from 7% in 2000, but has a very high case 
fatality rate. 
 
Tetanus is a neuromuscular disorder characterized 
by increased muscle tone and spasms. It is caused by 
tetano-spasmin, a toxin released by clostridium 
tetani [4]. Clostridium tetani, is a mobile gram-
positive spore forming obligate anaerobe with soil or 
dust as its natural habitat. It occurs worldwide but is 
endemic in developing countries and has continued 
to be a significant public health problem in resource-
poor nations [5]. Tetanus is a vaccine preventable 
disease and a significant cause of morbidity and 
mortality in developing countries. The disease is 
usually classified into neonatal and post neonatal 
tetanus in the pediatric age group [6].  
 
Aims and objectives 
The basic purpose of the study is to analyse the study 
on risk factors, vaccination status and outcome of 
tetanus in children. 
 
METHODOLOGY OF THE STUDY: 
This cross sectional study was conducted in PIMS, 
Islamabad during March 2018 to January 2019. The 
data was collected from 100 children of both 
genders. The diagnosis of tetanus was clinical, based 
on medical history and examination, determining the 
presence of at least three of the following clinical 
findings: severe trismus, refusal to feed, generalised 
muscle rigidity, opisthotonus or spontaneous tetanic 
spasms. Blood samples were taken within one hour 
of admission. Laboratory measurements included 
full blood count, electrolytes, creatinine and 
glucose.  
 
Statistical analysis 
All the data were analysed using SPSS version 21.0. 
All the values were expressed in mean and median 
range. 
 
RESULTS: 
The data was collected from 100 patients. There 
were 67(63.5%) males and 33 (36.5%) females. 
Overall, the mean age was 6.56+3.15 years, and the 
commonest age group at presentation was 6-10 years 
with 38(51.4%) cases. 50(67%) were unvaccinated, 
none (0%) had received booster dose and post-
trauma immune prophyl axis. The case fatality was 
therefore 61.8%, and did not vary significantly over 
the 14 years (P = 0.536). Age at admission, presence 
of inflamed umbilicus, prostration, number of spams 
per 5 minutes, NT score and presence of 
hypoglycaemia were all associated were all 
significantly associated with death in the uni-
variable analysis. 
Table 01: Mode of infection in tetanus cases 
Age (years) Non-protection detected by 
TQS 
 
Non-protection detected by 
ELISA 
  
n (%) OR (95% CI) n (%) OR (95% CI) 
1 22 (42.3) 1.00 24 (46.2) 1.00 
2 24 (40.0) 0.91 (0.43, 1.93) 24 (40.0) 0.78 (0.37, 1.65) 
3 33 (54.1) 1.61 (0.76, 3.39) 35 (57.4) 1.57 (0.75, 3.31) 
4 26 (76.5) 4.43 (1.69, 11.63) 25 (73.5) 3.24 (1.27, 8.27) 
5 24 (70.6) 3.27 (1.30, 8.21) 24 (70.6) 2.80 (1.12, 7.01) 
6 8 (50.0) 1.36 (0.44, 4.20) 8 (50.0) 1.17 (0.38, 3.58) 
7 6 (50.0) 1.36 (0.39, 4.80) 6 (50.0) 1.17 (0.33, 4.10) 
8 16 (88.9) 10.91 (2.27, 52.41) 15 (83.3) 5.83 (1.51, 22.60) 
9 7 (41.2) 0.95 (0.31, 2.90) 7 (41.2) 0.82 (0.27, 2.48) 
Total 166 (54.6) – 168 (55.3) – 
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DISCUSSION: 
That risk of non-protection against tetanus increases 
with increasing age was not surprising. Previous 
reports have shown that immunity against tetanus 
wanes with increasing age. Many of the caregivers 
who participated in the study could not provide 
tetanus immunization card, therefore it may be 
rational to administer booster dose of TT to children 
in similar situation, especially if they are male, not 
first born of their mothers and history of recent TT 
injection is lacking [7]. In addition, children who 
present with tetanus-prone wound in the emergency 
unit would benefit from anti-tetanus 
immunoglobulin. The strategy of immunizing at 
every opportunity is recommended by the Global 
Advisory Group of the WHO Expanded Programme 
on Immunization (EPI) since 1983 [8]. 
Tetanus has remained a public health problem in 
developing countries with high case fatality rates. 
Efforts of neonatal, childhood and maternal 
elimination through vaccination have faced 
challenges in these parts of the world due to low 
health awareness, shortage of human and material 
resources and poor health seeking behavior for 
trauma [9]. Due to the very nature of tetanus, 
hospital based studies are found to be an effective 
means for collecting information on the 
epidemiologic and clinical data on neonatal and 
childhood tetanus, and also for evaluating the impact 
of immunization programs [10]. 
CONCLUSION: 
It is concluded that this study has documented high 
case fatality rates in Pediatric tetanus in the study 
area. Closer follow-up of patients to identify the 
progress of severity assists in identifying cases that 
require respiratory support and drug escalation.  
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